Ironwood Pharmaceuticals Inc (IRWD): Cash & Equivalents
$215.46M
As of 2025-12-31
$79.13M
As of 2026-06-30
-31.0%
3-year compound annual growth
-9.9%
5-year compound annual growth
-1.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $215.46M | +143.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $88.56M | -3.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $92.15M | -86.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $656.20M | +5.8% | 2025-03-31, Balance as of period end |
| 2021-12-31 | $620.13M | +71.0% | 2024-02-16, Balance as of period end |
| 2020-12-31 | $362.56M | +104.8% | 2023-02-16, Balance as of period end |
| 2019-12-31 | $177.02M | +2.2% | 2022-02-18, Balance as of period end |
| 2018-12-31 | $173.17M | +37.7% | 2021-02-17, Balance as of period end |
| 2017-12-31 | $125.74M | +132.8% | 2020-02-13, Balance as of period end |
| 2016-12-31 | $54.00M | -79.3% | 2019-02-25, Balance as of period end |
| 2015-12-31 | $261.29M | +251.7% | 2018-02-22, Balance as of period end |
| 2014-12-31 | $74.30M | -1.6% | 2017-02-22, Balance as of period end |
| 2013-12-31 | $75.49M | -44.8% | 2016-02-19, Balance as of period end |
| 2012-12-31 | $136.70M | +56.6% | 2015-02-18, Balance as of period end |
| 2011-12-31 | $87.28M | +96.9% | 2014-02-07, Balance as of period end |
| 2010-12-31 | $44.32M | -63.8% | 2013-02-21, Balance as of period end |
| 2009-12-31 | $122.31M | n/a | 2012-02-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $215.46M | +143.3% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $53.83M | -38.1% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $111.04M | +55.0% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $144.84M | +256.3% |
| Harrow, Inc. (HROW) | 2025-12-31 | $72.93M | +54.4% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $174.93M | +141.9% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $142.90M | +42.2% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $230.52M | +56.5% |
| MannKind Corp (MNKD) | 2025-12-31 | $74.88M | +61.6% |
Compare IRWD, EOLS, XERS, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗